While the majority of patients possess autoantibodies against the acetylcholine receptor (AChR), antibodies targeting muscle-specific kinase (MuSK) and low-density lipoprotein receptor-related protein 4 (LRP4) have also been identified, indicating that MG comprises diverse subtypes based on antibody profiles [1]. The gene discussed is LRP4; the disease is myasthenia gravis.